Suffering from a chronic health condition is not as hopeless as it once was. Finally, there is good news on the horizon – in the form of a clinically supported ‘wonder’ enzyme known as Serrapeptase.
Serrapeptase may be new to many, but the anti-inflammatory enzyme has been restoring health for more than 40 years. Healthcare practitioners have observed its dramatic effects for more than four decades in countless applications, including blocked arteries, breast engorgement, fibrocystic breast disease, arthritis, inflammatory migraines and headaches, some cancers, and more. But what does the research say?
THE TOP TEN SERRAPEPTASE STUDIES
Based on user testimonials and clinical application, Serrapeptase can be used for almost any physical ailment as all health issues are derived from inflammation in the body. Even more importantly, Serrapeptase has scientific backing for this pain and inflammation relief. Serrapeptase research spans more than 40 years with new discoveries published regularly.
These top 10 Serrapeptase studies are only the tip of the iceberg.
1. Alzheimer’s Disease: In an exciting breakthrough for sufferers of this debilitating health condition, proteolytic enzymes Serrapeptase and Nattokinase were observed to effectively modulate some factors that characterise Alzheimer’s disease. l
2. Asthma: The relief chronic asthma sufferers have been looking for — researchers discovered that Serrapeptase supported the dissolution of sputum in asthma patients. 2
3. Breast Engorgement: Based on the use of anti-inflammatory Serrapeptase in a clinical setting, scientists now consider the enzyme to be “a safe and effective method for the treatment of breast engorgement.” 3
4. Carpal Tunnel Syndrome: Researchers believe that Serrapeptase enzyme therapy can be used as an effective alternative treatment for carpal tunnel syndrome.’ 4
5. Chronic Bronchitis: Bronchitis patients treated with Serrapeptase showed noticeably superior results compared to the treatment placebo group in reduced cough frequency, lessened expectoration, and loosened sputum. 5
6. Inflammation: Serrapeptase has broad clinical backing in its use as an ant-iinflammatory enzyme.6
7. Mucus Reduction: When taken orally, Serrapeptase can reduce the viscoelasticity of nasal mucus. 7
8. Postoperative Swelling: Following a third molar surgery, patients who took anti-inflammatory Serrapeptase observed a reduction in postoperative cheek swelling and pain intensity. 8
9. Sinusitis: Serrapeptase anti-inflammatory treatment offered noticeable improvement in patients with sinusitis, laryngitis, and catarrhal rhinopharyngitis.9
10. Wound Healing: Serratiopeptidase and metronidazole therapy supported improved wound healing in a clinical setting.10
THE ANSWER TO THE ALZHEIMER’S EPIDEMIC?
Perhaps the most astonishing new Serrapeptase research concerns its ability to treat Alzheimer’s disease. In 2013, a study was published detailing the effects of Serrapeptase and Nattokinase when administered daily for 45 days. Following the enzyme treatment, researchers observed a marked decrease in brain chemical activity that led to the development of Alzheimer’s disease. The enzyme treatment also greatly increased brain chemical activity that helped to protect against Alzheimer’s. 1
Alzheimer’s disease and a number of other chronic health conditions are often described as hopeless in the medical community. Unless you do some digging on your own or read The ‘Miracle’ Enzyme Is Serrapeptase, you’ll be hard-pressed to find a positive outlook for a devastating condition like Alzheimer’s.
Do not give up hope yet. New Serrapeptase research consistently reinforces what the natural health community has embraced for more than four decades. In combination with nutritional supplements and lifestyle changes, Serrapeptase can provide powerful long-term healthcare. In contrast, medications prescribed for a condition like Alzheimer’s will only provide disease management.
SERRAPEPTASE HEALTHCARE IS NOT DISEASE MANAGEMENT
You and your loved ones deserve better, and science is on your side. In most cases, you’ll find doctors who prescribe medication to ‘manage’ a chronic health condition. Disease management never addresses the root issue.
Fortunately, the powerful Serrapeptase enzyme has been prescribed by a growing number of doctors who take a comprehensive healthcare approach, including lifestyle and nutrition. These doctors may be in the minority, but they have research to back them. An enzyme like Serrapeptase can help to restore quality of life and promote disease recovery.
Vast research supports Serrapeptase to clear chronic inflammation and renew health. No matter what ails you. Serrapeptase can provide anti-inflammatory relief inflammatory relief when combined with a personalized health plan. Serrapeptase health plans may be followed for 30 days and can offer noticeable improvement in decreased symptoms, even for serious conditions like Alzheimer’s disease, Serrapeptase can help you get your life back. Look for a super 250,000iu’s of serrapeptase per capsule and then drop down to a lower amount for maintenance.
The world’s strongest Serrapeptase delivering 250,000iu Serrapetase per cap. Available 90 or 30 capsules (trial size) for serious health support and in delayed-release cap for optimum performance. Phthalate-free.
Unique powerful blend of x16 ingredients, including 80,000iu Serrapeptase and 1,600fu Nattokinase per cap, plus other digestive enzymes, antioxidants and
1. Fadl N. N., Ahmed, H. H. Booles H. F. and Sayed, A H. (2013) Serrapeptase and nattokjnase intervention for relieving Alzheimer’s disease pathophysiology in rat model Hum Exp Toxic0132 (7) pp. 721—35.
2. Taga T. and Mitsui, S. (1972). Effects of Serrapeptase in dissolution of sputum, especially in patients with bronchial asthma. Jap Clin Exp Med. 49 pp. 222-228.
3. Kee W Hv Tan S. L, Lee v, Salmon, Y, M. (1989) The treatment of breast engorgement with Serrapeptase a randomised double blind controlled trial Singapore Med J 30 (1) pp 48-54.
4 Panagariya, A and Sharma, A K (1999) A preliminary trial of Serratiopeptidase in patients with carpal tunnel syndrome J Assoc Physicians India 47 (12) pp. 1170—2.
5. Kase, Y. et al (1982) A new method for evaluating mucolytic expectorant activity and its application II. Application to two proteolytic enzymes, Serrapeptase and Seaprose Arznelrnitteltorachung. 32 pp 374-378.
6 Viswanatha Swamy, A H. M. and Patil. P A (2008) Effect of Some Clinically Used Proteolytic Enzymes on Inflammation in Rats. Indian J Pharm Sci. 70(1) pp. 114—117.
7. Majjma. Y et al (1990) Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus Am. Reu Respir. Dis. 141 pp. 79-83.
8. Al-Khateeb, T H. and Nusaic Y (2008) Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars Int J Oral Maxillofac Surg. 37(3) pp. 264-8.
9. Lee, H. S, Majima, Y,Saskakura, Y and Kim, B. W (1991) A technique for quantitative cytology of nasal secretions. Eur Arch Otorhinolaryngol. 248(7) pp. 406-8.
10. Rath, G.,Johal, E. S and Goyal A. K (2011) Development of serratiopeptidase and metronidazole based alginate microspheres for wound healing. Artif Cells Blood Substit Immobil Biotechnol 39(1) pp 44-50.